An important hypothesis about PD origins was recently published. The abstract conveys the rationale.(open access).
IMO, researchers Per Borghammer and Nathalie Van Den Berge may have clarified and connected the diverse findings in PD and related alpha synuclein pathologies.
I have long realized that the locus coeruleus is a major factor in my PD. My prodrome included sleep problems, leg cramps, and constipation. I am a gut first person. Also, I have documented autonomic issues.
A recent thread by Blackfeather addresses gut first or brain first.
healthunlocked.com/parkinso...
Which of the two major subgroups explained in the essay fits you?
Brain-First versus Gut-First Parkinson’s Disease: A Hypothesis.
IOS Press. Open access.
content.iospress.com/articl...
Abstract
Parkinson’s disease (PD) is a highly heterogeneous disorder, which probably consists of multiple subtypes. Aggregation of misfolded alpha-synuclein and propagation of these proteinacious aggregates through interconnected neural networks is believed to be a crucial pathogenetic factor. It has been hypothesized that the initial pathological alpha-synuclein aggregates originate in the enteric or peripheral nervous system (PNS) and invade the central nervous system (CNS) via retrograde vagal transport. However, evidence from neuropathological studies suggests that not all PD patients can be reconciled with this hypothesis. Importantly, a small fraction of patients do not show pathology in the dorsal motor nucleus of the vagus. Here, it is hypothesized that PD can be divided into a PNS-first and a CNS-first subtype. The former is tightly associated with REM sleep behavior disorder (RBD) during the prodromal phase and is characterized by marked autonomic damage before involvement of the dopaminergic system. In contrast, the CNS-first phenotype is most often RBD-negative during the prodromal phase and characterized by nigrostriatal dopaminergic dysfunction prior to involvement of the autonomic PNS. The existence of these subtypes is supported by in vivo imaging studies of RBD-positive and RBD-negative patient groups and by histological evidence— reviewed herein. The present proposal provides a fresh hypothesis-generating framework for future studies into the etiopathogenesis of PD and seems capable of explaining a number of discrepant findings in the neuropathological literature.
J Parkinsons Dis, 9 (s2), S281-S295.
Authors: Per Borghammer 1 2, Nathalie Van Den Berge 2.
Affiliations:
1Nuclear Medicine and PET, Aarhus University Hospital, Aarhus, Denmark.
2Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
PMID: 31498132.
****.
See also:
PMC ANS: The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort.
ncbi.nlm.nih.gov/pmc/articl...
****.
Search HU PD for Autonomic and for Coeruleus.